Skip to main content
. Author manuscript; available in PMC: 2019 Jun 21.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1322–1328. doi: 10.1158/1055-9965.EPI-07-2591

Table 4.

Joint effects of DRC with SHS exposure and with lung cancer family history

Controls, n (%) Cases, n (%) OR* (95% CI*) P

DRC SHS exposure
 Optimal No 45 (19.9)    10 (7.2) 1
 Optimal Yes 70 (31.0) 49 (35.3) 2.68 (1.29–5.56) 0.0081
 Suboptimal No 32 (14.2) 20 (14.4) 2.94 (1.58–5.48) 0.0007
 Suboptimal Yes 79 (35.0) 60 (43.2) 3.81 (2.26–6.41) <0.0001
Family history of lung cancer
 Optimal No 44 (30.2) 23 (25.8) 1
 Optimal Yes 17 (11.6) 7 (7.9) 0.59 (0.24–1.48) 0.2610
 Suboptimal No 68 (46.6) 40 (44.9) 1.40 (0.86–2.29) 0.1780
 Suboptimal Yes 17 (11.6) 19 (21.4) 2.49 (1.11–5.60) 0.0276
Family history of non-smoking-related cancer
 Optimal No 44 (19.6) 23 (13.7) 1
 Optimal Yes 59 (26.2) 37 (22.0) 1.15 (0.46–2.91) 0.7627
 Suboptimal No 68 (30.2) 40 (23.8) 1.31 (0.78–2.19) 0.3042
 Suboptimal Yes 54 (24.0) 68 (40.5) 2.88 (1.32–6.28) 0.0081
*

Adjusted for age, gender, ethnicity, dust exposure, and presence of asthma and hay fever and grouped by year of assay using generalized estimating equation model; DRC adjusted for the laboratory variables.